Bronnen: wij volgen de wijzigingen op basis van informatie van het College ter Beoordeling van Geneesmiddelen (CBG) — de Geneesmiddeleninformatiebank (inschrijvingen en doorgehaalde handelsvergunningen, dagelijks vergeleken) en DHPC-brieven — en van de Inspectie Gezondheidszorg en Jeugd (terugroepacties). Besluiten over centraal toegelaten geneesmiddelen komen uit het Uniebestand van de Europese Commissie (EU-label). Voor tekorten en vergoedingen bestaan in Nederland geen open overheidsgegevens; die staan hier (nog) niet. Alternatieven met dezelfde werkzame stof: database van Lekoskop.
nr. EU/1/18/1321 · toegelaten op 27-09-2018 · Gefitinib Mylan is indicated as monotherapy for the treatment of adult patients with locally advanced or metas… · Mylan Pharmaceuticals Limited · gefitinib · ATC L01EB01
nr. EU/1/24/1859 · Yuvanci is indicated as substitution therapy for the long-term treatment of pulmonary arterial hypertension (P… · Janssen-Cilag International NV · Macitentan / Tadalafil · ATC C02KX54
nr. EU/1/14/982 · toegelaten op 15-01-2015 · Viekirax is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (C… · AbbVie Deutschland GmbH & Co. KG · ombitasvir / paritaprevir / ritonavir · ATC J05AP53
nr. EU/1/14/983 · toegelaten op 15-01-2015 · Exviera is indicated in combination with other medicinal products for the treatment of chronic hepatitis C (CH… · AbbVie Deutschland GmbH & Co. KG · dasabuvir · ATC J05AP09
nr. EU/1/24/1863 · Adult Crohn’s Disease
Otulfi is indicated for the treatment of adult patients with moderately to severely act… · Fresenius Kabi Deutschland GmbH · ustekinumab · ATC L04AC05
nr. EU/1/24/1862 · Plaque psoriasis
Fymskina is indicated for the treatment of moderate to severe plaque psoriasis in adults who… · Formycon AG · ustekinumab · ATC L04AC05
nr. EU/1/24/1856 · Vyloy, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the first … · Astellas Pharma Europe B.V. · zolbetuximab · ATC L01FX31
nr. EU/1/24/1857 · Treatment of moderate to severe dry eye disease (keratoconjunctivitis sicca) in adult patients, which has not … · Laboratoires Thea · ciclosporin · ATC S01XA18
nr. EU/1/24/1864 · Breast cancer
Metastatic breast cancer
Tuznue is indicated for the treatment of adult patients with HER2… · Prestige Biopharma Belgium BVBA · trastuzumab · ATC L01FD01
nr. EU/1/24/1853 · LOQTORZI, in combination with cisplatin and gemcitabine, is indicated for the first line treatment of adult pa… · Topalliance Biosciences Europe Limited · toripalimab · ATC L01FF13
nr. EU/1/24/1854 · KAYFANDA is indicated for the treatment of cholestatic pruritus in Alagille syndrome (ALGS) in patients aged 6… · Ipsen Pharma · Odevixibat · ATC A05AX
nr. EU/1/24/1861 · Ituxredi is indicated in adults for the following indications:
Non-Hodgkin’s lymphoma (NHL)
Ituxredi is … · Reddy Holding GmbH · Rituximab · ATC L01FA01
nr. EU/1/24/1855 · Iqirvo is indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic… · Ipsen Pharma · elafibranor · ATC A05AX06
nr. EU/1/24/1847 · Axitinib Accord is indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC) afte… · Accord Healthcare S.L.U. · axitinib · ATC L01EK01
nr. EU/1/24/1851 · Anzupgo is indicated for the treatment of moderate to severe chronic hand eczema (CHE) in adults for whom topi… · LEO Pharma A/S · delgocitinib · ATC D11AH11
nr. EU/1/13/826 · toegelaten op 22-04-2013 · Treatment of patients with moderate to severe Alzheimer’s disease. · Pharmathen S.A. · Memantine · ATC N06DX01
Lekoskop